Structured Summary
Abstract
A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
2 entry terms
- Antegren
- Tysabri
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (2002)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Natalizumab. Medical Subject Headings (MeSH). 2026. Unique ID D000069442. http://id.nlm.nih.gov/mesh/2026/D000069442
- Natalizumab. In: Wikipedia. https://en.wikipedia.org/wiki/Natalizumab
- Natalizumab. In: Wikidata. https://www.wikidata.org/wiki/Q386119